Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when VNRX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsVolitionRx reports Q1 2026 financial results, schedules earnings call for May 15
Filed May 14, 2026 · Period ending May 14, 2026 · ~1 min read
Key Changes
-
medium
VolitionRx issued a press release announcing first quarter 2026 financial results and business updates for the period ended March 31, 2026. Specific financial figures are contained in the attached press release exhibit.
Item 2.02 verify on EDGAR → -
low
Management scheduled an earnings conference call for May 15, 2026 at 8:30 a.m. Eastern Time to discuss quarterly results with investors and analysts.
Item 2.02 verify on EDGAR →
Summary
VolitionRx announced its first quarter 2026 financial results through a press release on May 14, 2026. The company disclosed both financial performance and business updates for the three months ended March 31, 2026, though the specific figures and details are contained in the press release exhibit rather than the 8-K filing itself. For retail investors, this is a routine quarterly earnings announcement.
The scheduled conference call on May 15 provides an opportunity to hear management's commentary on the quarter and ask questions about the company's performance and outlook. Watch for the actual financial metrics in the press release and any forward guidance management provides during the call, as these will indicate whether the company is meeting its operational and financial targets.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
Item 2.02 — Results of Operations and Financial Condition filed; see Key Changes for terms.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
The Company also confirmed its conference call to be held on May 15, 2026 at 8:30 a.m. U.S. Eastern Time.
Management scheduled an earnings conference call for the day following the press release to discuss the quarterly results with investors and analysts. This provides an opportunity for stakeholders to ask questions about the company's performance and outlook.
Event · Item 9.01 — Financial Statements and Exhibits
VolitionRx filed an 8-K attaching a press release dated May 14, 2026; no material business event disclosed in the filing body.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
Press Release of VolitionRx Limited, dated May 14, 2026.
The 8-K references an attached press release dated May 14, 2026 (Exhibit 99.1). The filing body itself contains no substantive disclosure about the press release content, making this a procedural filing. The actual material information would be in the press release exhibit, which is not included in the provided text.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · May 25, 2026 · How we verify